Amylyx Pharmaceuticals, Inc. Inventory
Amylyx Pharmaceuticals, Inc. (AMLX) had Inventory of $38.32 million as of 2023-12-31, per its 10-K filed 2025-03-04.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryNet · last filed 2025-03-04
- 2023-12-31: Inventory, Net $38.32M.
- 2023-09-30: Inventory, Net $32.37M.
- 2023-06-30: Inventory, Net $24.86M.
- 2023-03-31: Inventory, Net $13.07M.
| Period end | Inventory, Net |
|---|---|
| 2023-12-31 | $38.32M 10-K · filed 2025-03-04 |
| 2023-09-30 | $32.37M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $24.86M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $13.07M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $9.77M 10-K · filed 2024-02-22 |
| 2022-09-30 | $563.00K 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |